Impact of ACSL4 on the prognosis of hepatocellular carcinoma: Association with cancer-associated fibroblasts and the tumour immune microenvironment.

Katsuya ToshidaShinji ItohNorifumi IsedaTakahiro TomiyamaShohei YoshiyaTakeo ToshimaYu-Chen LiuTakeshi IwasakiDaisuke OkuzakiKoji TaniguchiYoshinao OdaMasaki MoriTomoharu Yoshizumi

Published in: Liver international : official journal of the International Association for the Study of the Liver (2024)

ACSL4 is a prognostic factor in HCC patients and its expression was associated with cancer-associated fibroblasts and anti-tumour immunity.

Keyphrases

prognostic factors
end stage renal disease
ejection fraction
newly diagnosed
poor prognosis
stem cells
extracellular matrix
peritoneal dialysis
patient reported outcomes